Azelis Group NV
F:2R7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Azelis Group NV
F:2R7
|
BE |
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
US |
|
M
|
Metalore Resources Ltd
OTC:MTLRF
|
CA |
|
China Resources Beer Holdings Co Ltd
F:CHK0
|
HK |
|
OneWater Marine Inc
NASDAQ:ONEW
|
US |
|
D2L Inc
F:NE5
|
CA |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
V
|
Vinci SA
XHAM:SQU
|
FR |
|
Corporate Travel Management Ltd
ASX:CTD
|
AU |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
A
|
Autodesk Inc
F:AUD
|
US |
Intrinsic Value
Is 2R7 undervalued or overvalued?
See the intrinsic value estimate for 
Azelis Group NV and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Azelis Group Does
Azelis Group is a specialty chemicals and food ingredients distributor. It buys products from chemical and ingredient makers and sells them to manufacturers that need those materials to make things like personal care products, food and beverages, cleaning products, coatings, and pharmaceuticals. In plain terms, Azelis sits in the middle of the supply chain and helps connect suppliers of raw materials with the companies that use them.
- Headquarters
- Belgium BE
- Employees
- 4 000
- IPO date
- Sep 17, 2021
Azelis Group has no economic moat
Azelis Group NV lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Azelis Group NV
The intrinsic value for Azelis Group NV (2R7) under the Base Case is hidden EUR.
Compared with the current market price of 11.7 EUR, the stock appears hidden.
